GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | JAK2 | decreases expression | EXP | | 6480464 | CTD | Arsenic Trioxide results in decreased expression of JAK2 protein | PMID:11721366 PMID:36352148 | JAK2 | decreases phosphorylation | EXP | | 6480464 | CTD | Arsenic Trioxide results in decreased phosphorylation of JAK2 protein | PMID:29409467 | JAK2 | increases expression | EXP | | 6480464 | CTD | Arsenic Trioxide results in increased expression of JAK2 mRNA | PMID:29633893 | JAK2 | multiple interactions | EXP | | 6480464 | CTD | [ruxolitinib co-treated with Arsenic Trioxide] results in decreased phosphorylation of JAK2 protein; Arsenic Trioxide inhibits the reaction [IL6 protein results in increased phosphorylation of JAK2 protein]; Arsenic Trioxide promotes the reaction [Curcumin results in decreased expression of JAK2 protein]; pervanadate inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of JAK2 protein]; PTPN6 protein affects the reaction [Arsenic Trioxide results in decreased phosphorylation of JAK2 protein] | PMID:12492118 PMID:29409467 PMID:30012499 PMID:36352148 | |
Go Back to source page | Continue to Ontology report |